Work

Abstract A27: Dual PI3K/BRD4 (kinase/epigenetic) inhibitors for maximal MYC control in cancer therapeutics

Year: 2015

Type: conference-abstract

Source: Molecular Cancer Therapeutics

DOI: 10.1158/1538-8514.pi3k14-a27

Authors: Alok R. Singh, Shweta Joshi, Joseph R. Garlich, Guillermo A. Morales, Donald Lee Durden

Institutions: University of California San Diego, SignalRx Pharmaceuticals (United States)

Language: English

Topic: Protein Degradation and Inhibitors

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2411436324

Cites:

Cited by: 3

Related to: 10